1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Pharmaceuticals and Healthcare Report Q4 2016

United States Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 112 pages

Includes 3 FREE quarterly updates



BMI View: The number of new drugs approved by the FDA every year will continue to rise steadily, thoughthis will, at least over the short term, be at a slower rate than what was seen over the 2006-2015 period.Due to advances in genomics and personalised medicines, many of the new drugs set for approval willaddress small patient populations. As such, the forecast for higher numbers of new medicine approvals isnot indicative of improved R&D productivity and greater industry profitability.

Headline Expenditure Projections

- Pharmaceuticals: USD333bn in 2015 to USD354bn in 2016; +6.1% growth. Market forecastrevised upwards since Q316 due to consideration and incorporation of new macroeconomic data.

- Healthcare: USD3,139bn in 2015 to USD3,278bn in 2016; +4.4% growth. Forecast revised downwardssince Q316 following reassessment of market dynamics.

Table Of Contents

United States Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United States 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United States 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United States 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (United States 2014-2020) 31
Industry Risk Reward Index 32
Americas Risk/Reward Index 32
United States Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Issues 56
Pricing and Reimbursement Regime 57
The November 2016 Presidential Election 59
Market Overview 61
Healthcare Sector 62
Table: Key Features Of The Affordable Care Act By Year 64
Table: Healthcare Resources (United States 2010-2015) 67
Table: Healthcare Personnel (United States 2010-2015) 67
Table: Healthcare Activity (United States 2010-2015) 68
Clinical Trials 68
Epidemiology 70
Competitive Landscape 73
Research-Based Industry 73
Table: Multinational Market Activity 73
Pharmaceutical Distribution 75
Pharmaceutical Retail Sector 75
Company Profile 76
Amgen 76
AstraZeneca 81
Eli Lilly 85
GlaxoSmithKline 89
Merck and Co 93
Pfizer 97
Demographic Forecast 101
Table: Population Headline Indicators (United States 1990-2025) 102
Table: Key Population Ratios (United States 1990-2025) 102
Table: Urban/Rural Population and Life Expectancy (United States 1990-2025) 103
Table: Population By Age Group (United States 1990-2025) 103
Table: Population By Age Group % (United States 1990-2025) 104
Glossary 106
Methodology 108
Pharmaceutical Expenditure Forecast Model 108
Healthcare Expenditure Forecast Model 108
Notes On Methodology 109
Risk/Reward Index Methodology 110
Index Overview 111
Table: Pharmaceutical Risk/Reward Index Indicators 111
Indicator Weightings 112

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Download Unlimited Documents from Trusted Public Sources

Generic Drug Industry in the US

  • September 2016
    9 pages
  • Generic Drug  

  • United States  

View report >

Opioid and Therapy Market in the US

  • September 2016
    11 pages
  • Opioid  

    Therapy  

    Analgesic  

  • United States  

View report >

Opioid Market in the US

  • September 2016
    13 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • United States  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.